INVESTOR ALERT: Levi & Korsinsky, LLP Announces Investigation Concerning the Fairness of the Sale of Anacor Pharmaceuticals, ...

NEW YORK, May 17, 2016 /PRNewswire/ -- The following statement is being issued by Levi & Korsinsky, LLP:

To: All Persons or Entities who purchased Anacor Pharmaceuticals, Inc. (NASDAQ: ANAC) stock prior to May 16, 2016.

You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of the sale of Anacor Pharmaceuticals to Pfizer Inc. (NYSE: PFE) for $99.25 in cash per share. To learn more about the action and your rights, go to:

http://zlk.9nl.com/anacor-pharmaceuticals-anac

or contact Joseph E. Levi, Esq. either via email at [e-mail] or by telephone at [phone], toll-free: [phone]. There is no cost or obligation to you.

Levi & Korsinsky is a national firm with offices in New York, New Jersey, Connecticut, California, and Washington D.C. The firm's attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities lawsuits and have recovered hundreds of millions of dollars for aggrieved shareholders. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.

Levi & Korsinsky, LLP
Joseph Levi, Esq.
Eduard Korsinsky, Esq.
30 Broad Street - 24th Floor
New York, NY 10004
Tel: [phone]
Toll Free: [phone]
Fax: [phone]
www.zlk.com

Logo - http://photos.prnewswire.com/prnh/20120409/MM84375LOGO

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/investor-alert-levi--korsinsky-llp-announces-investigation-concerning-the-fairness-of-the-sale-of-anacor-pharmaceuticals-inc-to-pfizer-inc-for-9925-per-share----anac-300270252.html

SOURCE Levi & Korsinsky, LLP

Copyright 2016 PR Newswire